We find genetic answers to help you make important decisions about your health.
MiraKind conducts cutting-edge research on a new class of genetic markers that provides powerful information about personalized disease risk, prevention and treatment.
What We Do
MiraKind conducts patient-centric research to better understand novel inherited gene mutations, such as the KRAS-variant, to help:
Discover answers in our DNA to identify individuals who are at a higher risk of certain diseases, such as cancer.
Apply answers to help prevent disease through personalized prevention strategies based on one's unique genetics.
Recommend the most effective cancer treatment, based on an individual’s unique response to therapy.
FROM THE DECEMBER 2014 ISSUE
Despite the dangers of the KRAS-variant mutation, few doctors have heard of it. But one researcher is trying to change that.